Current Opinion in Oncology

Article	Citations
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps	55
The road to chemotherapy-free treatment in chronic lymphocytic leukaemia	38
Can febrile neutropenia re-invent its self?	32
Challenges adopting next-generation sequencing in community oncology practice	30
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	28
Angiogenesis inhibition in lung cancer: emerging novel strategies	26
Pathologic diagnosis of lung cancer – recent developments	25
Hepatosplenic T-cell lymphoma: treatment challenges	21
Treatment of anaplastic gliomas: evidences and controversies	21
Editorial introductions	20
Editorial: Head and neck squamous cell cancer: ways to optimize the treatment and improve the outcomes	19
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	17
Editorial introductions	17
Opportunities and challenges of neoadjuvant targeted therapy in nonsmall cell lung cancer	17
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	16
Breast surgery after neoadjuvant therapy	16
Postneoadjuvant treatment for triple-negative breast cancer	15
Bacterial infection-driven lymphomagenesis	15
Psycho-oncology interventions focusing on fatigue and sleep disturbances	15
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	14
Treatments and challenges in advanced prostate cancer	13
Editorial: Psychological interventions in oncology: advances and challenges	13
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	13
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	13
Adjuvant and neoadjuvant approaches in pancreatic cancer	12

Evolving systemic management of urothelial cancers	12
New strategies for the treatment of breast cancer with leptomeningeal metastasis	12
Preclinical glioma models in neuro-oncology: enhancing translational research	12
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	11
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	10
Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology	10
Antibody-drug conjugates in solid tumors: a new frontier	10
New targeted therapies in liposarcoma: state of art and future perspectives	10
Survivorship after Hodgkin lymphoma and the right to be forgotten	10
Immune checkpoint inhibitors as adjuvant therapy in patients with completely resected nonsmall cell lung cancer	9
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	9
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	9
New treatments for desmoid tumors	9
The multiple molecular dimensions of long noncoding RNAs that regulate gene expression and tumorigenesis	9
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	9
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	8
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	8
Genomic tests for risk stratification in patients with early human epidermal growth factor receptor 2-positive breast cancer	8
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	8
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	8
Harnessing dendritic cells for innovative therapeutic cancer vaccines	7
Novel immunotherapy combinations in head and neck squamous cell carcinoma	7
Nanoparticle therapy for head and neck cancers	7
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives	7
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials	7
Role of PSMA PET/CT in imaging and management of prostate cancer	7
Pathology and new insights in thyroid neoplasms in the 2022 WHO classification	7
HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management	7
Unveiling the enigma of the blood–brain barrier in glioblastoma: current advances from preclinical and clinical studies	7
Advances in the treatment of light chain amyloidosis	7
Burnout among health professionals working in oncology: current evidence and challenges for future research	7
Recent advances in allogeneic transplantation for acute myeloid leukemia	6
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma	6
Targeting SUMOylation in cancer	6
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
Targeting cancer stem cell pathways for lung cancer therapy	6
Integrating new oral selective oestrogen receptor degraders in the breast cancer treatment	6
The role of biomarkers in the management of HPV-related oropharyngeal cancer	6
Editorial: Supportive care in cancer patients: quo vadis?	6
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma	6
2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy	6
Editorial introductions	6
BRAF mutations in thyroid cancer	6
How to prevent human papillomavirus-related oropharyngeal cancer?	5
Venetoclax in combination with nucleoside analogs in acute myelogenous leukemia	5
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	5
Impact of sentinel node implementation in gynecologic cancers	5
New molecular entities of soft tissue and bone tumors	5
Question prompt lists to improve communication between cancer patients and healthcare professionals	5

State of the art and future directions in the systemic treatment of medullary thyroid cancer	5
Safety of assisted reproductive techniques in gynecological cancer patients	5
Editorial introductions	5
Editorial introductions	5
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	5
Surgical management of skull base meningiomas and vestibular schwannomas	5
New hopes in relapsed refractory primary central nervous system lymphoma	5
CIC-DUX4 sarcomas	5
Image-guided surgery in oral cancer: toward improved margin control	5
Challenges in the management of relapsed germ cell tumors	5
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	5
New horizons in early drugs development in solid cancers	5
Editorial introductions	5
Prophylactic cranial irradiation in small cell lung cancer: an update	5
Editorial: precision medicine of sarcomas and aggressive connective tissue tumours: from one-size-fits-all to haute couture	5
Unveiling the role of cellular dormancy in cancer progression and recurrence	4
Are advancements in screening technology contributing to breast cancer over-diagnosis?	4
Recent advances in radiosensitivity determinants in melanoma	4
Educational needs of self-care in cachectic cancer patients and caregivers	4
Biomarkers and immunotherapy: where are we?	4
Biomarker-directed therapy in multiple myeloma	4
Treatment of radiation-associated angiosarcoma	4
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	4
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	4
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	4
Bromodomain and extraterminal domain protein bromodomain inhibitor based cancer therapeutics	4
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	4
Tropomyosin receptor kinases in sarcomas – of joy and despair	4
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	4
Editorial: Advanced care planning	4
Stereotactic ablative radiation therapy in metastatic prostate cancer	4
Benefits of sentinel node detection in cervical cancer	4
Application of natural killer immunotherapy in blood cancers and solid tumors	4
Ten steps to establish a national centre for gestational trophoblastic disease	4
Is less more in the surgical treatment of early-stage cervical cancer?	4
Novel therapeutics in refractory germ cell tumors	4
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	4
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	4
Immunotherapy in first line treatment of adult acute lymphoblastic leukemia	4
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	4
Immunotherapy and breast cancer: an overview	3
Immunotherapies in non-metastatic gastrointestinal cancers	3
What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?	3
Editorial introductions	3
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?	3
Immunomodulation for hepatocellular carcinoma therapy: current challenges	3
Measurable residual disease in peripheral blood in myeloma: dream or reality	3
Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment	3
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia	3
Editorial introductions	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
Treatment of small cell lung cancer: recent advances	3
New targeted treatments for advanced sarcomas	3
Advances in testing for human papillomavirus-mediated head and neck cancer	3
Editorial introductions	3
Accelerating drug access from advanced to early breast cancer: the special case of oral selective estrogen receptor degraders	3
Management of metastatic melanoma with new immunotherapy approaches beyond PD-1/CTLA-4 inhibitors	3
Use of staging for sex cord stromal tumours	3
Current treatments of medulloblastoma	3
Transcriptional and epigenetic control of early life cell fate decisions	3
Current limits of conservative treatment in ovarian cancer	3
Genetic testing in patients with triple-negative or hereditary breast cancer	3
Importance of guidelines and networking for the management of rare gynecological cancers	3
The role of next-generation sequencing in acute myeloid leukemia	3
What is the best salvage therapy for Hodgkin lymphoma?	3
The conquest of lung cancer in Central Europe	3
Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer	3
Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer	3
Biomarkers in advanced renal cell carcinoma: current practice and future directions	3
Prognostic factors in primary central nervous system lymphoma	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Next questions for the medical treatment of gastrointestinal stromal tumor	2
Preclinical models to understand the biology and to discover new targets in brain metastases	2
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	2
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	2
Cancer-associated thrombosis: what is new?	2
Tripartite motif family – its role in tumor progression and therapy resistance: a review	2
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	2
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	2
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	2

How to treat localized Hodgkin lymphoma?	2
Potential subtype-specific therapeutic approaches in small cell lung cancer	2
Editorial introductions	2
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	2
Editorial: Chromatin dynamics and immunosurveillance – two sides of the cancer ‘cell identity crisis’	2
Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers	2
Mutational burden and immune recognition of gliomas	2
Liquid biopsy in brain tumors: moving on, slowly	2
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	2
Editorial Introductions	2
Editorial Introductions	2
Clinical management of brain tumors in pregnancy	2
Gynecological sarcomas: literature review of 2020	2
Recent advances in precision medicine for acute myeloid leukemia	2
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	2
New boundaries for fertility sparing management in endometrial cancer	2
Imaging for illuminating actionable pathways in breast cancer	2
Achievements of international rare cancers networks and consortia in the neuro-oncology field	2
Hairy cell leukemia: a brief update on current knowledge and treatment prospects	2
Current treatment options for nodular lymphocyte-predominant Hodgkin lymphoma	2
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	2
Ovarian preservation in gynecologic oncology: current indications and techniques	2
How to monitor the side effects of treatments in cancer patients	2
Radiation therapy on the axilla after neoadjuvant chemotherapy	2
New perspectives in liquid biopsy for glioma patients	2
Thinking through the multimodal treatment of localized oesophageal cancer: the point of view of the surgeon	2
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights	2
Altered hormone expression induced genetic changes leads to breast cancer	2
Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials	2
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	1
Advance care planning in oncology: a scoping review and some recommendations	1
Active surveillance in favorable intermediate risk prostate cancer: outstanding questions and controversies	1
Preoperative immunotherapy for head and neck cancers: state of art	1
Maintenance therapies in acute myeloid leukemia: the renaissance of an old therapeutic concept	1
Highlights of recent research focused on the treatment of advanced prostate cancer	1
Mind the target: circulating tumour DNA in gastrointestinal malignancies	1
Emerging therapies in Ewing sarcoma	1
Molecular testing of DNA damage response pathways in prostate cancer patients	1
Next-generation sequencing for the management of sarcomas with no known driver mutations	1
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	1
Update on bi-specific monoclonal antibodies for blood cancers	1
Collaborative centralization of gynaecological cancer care	1
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	1
Editorial introductions	1
Action against thoracic cancers: recent achievements and perspectives	1
New developments in rare vulvar and vaginal cancers	1
Updated concepts in treatment of giant cell tumor of bone	1
Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma	1
Molecular and nutritional markers in head and neck cancer	1
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	1
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas	1
Immunotherapy in rare ovarian cancer	1
Treatment updates on tenosynovial giant cell tumor	1
Psychological interventions targeting patients with metastatic cancer and prolonged survival expectancies: advances and challenges	1
Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma	1
Prophylactic cranial irradiation for small cell lung cancer in the era of immunotherapy and molecular subtypes	1
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019–2021	1
First line treatments in primary central nervous system lymphomas in young patients	1
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	1
Fms-like tyrosine kinase 3 positive acute myeloid leukemia	1
Circulating tumor DNA in breast cancer: a biomarker for patient selection	1
Polyamine metabolism in prostate cancer	1
Editorial: Lung cancer: continuous progress in diagnosis and treatment	1
Advances in myelodysplastic syndrome	1
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	1
Different tracers for sentinel node detection in gynecologic oncology	1
The role of the microbiome in skin cancer development and treatment	1
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	1
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	1
Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program	1
Sarculator: how to improve further prognostication of all sarcomas	1
Following your gut: the emerging role of the gut microbiota in predicting and treating immune-related adverse events	1
State of the art and future directions in the systemic treatment of neuroendocrine neoplasms	1
Oral microbiome as a new research-target for supportive care and precision oncology	1
Novel next-generation sequencing-based methodologies to characterize the mutational consequences of (prenatal) chemotherapy exposure in noncancerous tissue	1
Fasting-mimicking diet: a metabolic approach for the treatment of breast cancer	1
Novel vaccines against lung cancer	1
Improved guideline adherence in oncology through clinical decision-support systems: still hindered by current health IT infrastructures?	1
HIV-related lymphomas	1
The role and underlying mechanisms of tumour-derived exosomes in lung cancer metastasis	1
Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?	1
Editorial introductions	1